Past Issues

• 8

  COVID-19 as a Catalyst for Digital Transformation of Clinical Research: Are we there yet?

  Dr. Ammar Raza, Regional Medical Director- Middle East and Africa, Allergan Aesthetics, AbbVie company, Dubai

• 19

  Data Connectivity and Collaboration in Life Sciences and Healthcare Supply Chain

  David Bang, Global Vice President Strategic Development, Hellmann Worldwide Logistics

• 20

  Three C’s to Enable Continuous Development and Manufacturing for Small Molecule Active Pharmaceutical Ingredient

  Nick Thomson, Senior Director, Chemical Research and Development, Pfizer Inc

• 22

  De-risking the preclinical phase of immunotherapy drug development

  Ralph Gareus, Director Business Development, The Jackson Laboratory

• 25

  Managing Impacts of Technology Transformations in Pharmacovigilance

  Olga Minkov, Executive Director, Operations - Pharmacovigilance & Epi, Gilead Sciences

• 28

  In our new digital reality, conveying and driving empathy will be critical to the future of healthcare

  Ankit Vahia, Executive Strategy Director, Pharma/ Health and Wellness, Grey Group

• 30

  Driving Digital Transformation in the Pharma Industry

  Wayne Hull, Chief Digital & Technology Officer, PCI Pharma Services